Anti-HBV placenta transfer factor (Sepaso Pharmaceutical)

抗乙型肝炎胎盘转移因子

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-HBV placenta transfer factor (Sepaso Pharmaceutical)
Drug Alias Name泰来肽维尔甘康
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesXibaishou Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXibaishou Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeA05
Related LinksN/A